| A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney. (NCT02186925) | Meir Medical Center | 2014-08-01 |
| Impact of Geriatrician Interventions on Chemotherapy Delivery in Vulnerable Elderly Oncology Patients (NCT02785887) | Azienda USL 4 Prato | 2014-08-01 |
| Early-Phase Safety of Proton Therapy Equipment (NCT02315989) | Chang Gung Memorial Hospital | 2014-08-01 |
| Detection of Lymphnodes Using ICG During RARP (NCT02163083) | St. Antonius Hospital Gronau | 2014-08-01 |
| Prevention of Lymphoceles After Robotic PLND (NCT02035475) | OhioHealth | 2014-08-01 |
| Multicenter Trial of Abiraterone Acetate With or Without Cabazitaxel in Treatment of Metastatic Castration Resistant Prostate Cancer (NCT02218606) | Memorial Sloan Kettering Cancer Center | 2014-08-01 |
| A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer (NCT02142608) | Bracco Diagnostics, Inc | 2014-08-01 |
| Personal Web Page In Clinical Trial Participant Education (NCT03887091) | Dana-Farber Cancer Institute | 2014-07-21 |
| 18F-DCFBC PET/CT in Prostate Cancer (NCT02190279) | National Cancer Institute (NCI) | 2014-07-12 |
| DEPORRA-CoProst: Assessment of New Fluorescence Imagery Techniques Using Prostate Chips From Transurethral Resections (NCT02185170) | University Hospital, Grenoble | 2014-07-01 |
| Stellate Ganglion Block for Hot Flushes in Men Treated With ADT (NCT02295163) | Rijnstate Hospital | 2014-07-01 |
| Metformin for Rising PSA Remote Trial (NCT02376166) | Matthew Galsky | 2014-07-01 |
| Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy (NCT02247960) | University of Rochester | 2014-07-01 |
| Spanish Urological Association Registry of Patients on Active Surveillance (NCT02865330) | Fundación Instituto Valenciano de Oncología | 2014-07-01 |
| MR-guided Focal Laser Ablation of the Prostate (NCT02200809) | Radboud University Medical Center | 2014-07-01 |
| Study In Urology Practices Looking At Impact Of OncotypeDX GPS Test On Men Choosing And Remaining On Active Surveillance (NCT03502213) | Genomic Health®, Inc. | 2014-07-01 |
| A Pilot Study of the Feasibility of Chronic Cavernous Nerve Stimulation to Promote Regeneration and Erectile Function (NCT02006927) | Kenneth M Peters, MD | 2014-07-01 |
| 68Ga-NOTA-BBN-RGD PET/CT in Prostate Cancer Patients (NCT02747290) | Peking Union Medical College Hospital | 2014-07-01 |
| LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel (NCT02182622) | Martin Gutierrez | 2014-07-01 |
| Phase II Investigation of Prostate Artery Embolization (PAE) Before Radical Prostatectomy in Prostate Cancer Patients (NCT02173522) | Shivank Bhatia | 2014-07-01 |
| Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) (NCT02179515) | National Cancer Institute (NCI) | 2014-06-28 |
| Radium Ra 223 With Enzalutamide Compared to Enzalutamide Alone in Men With Metastatic Castration Refractory Prostate Cancer (NCT02199197) | University of Utah | 2014-06-25 |
| Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy (NCT06167824) | IRCCS San Raffaele | 2014-06-19 |
| Navigator Guided e-Psychoeducational Intervention (NCT02186444) | H. Lee Moffitt Cancer Center and Research Institute | 2014-06-02 |
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) (NCT02054793) | Emmanuel Antonarakis, MD | 2014-06-01 |
| Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer (NCT02135445) | Millennium Pharmaceuticals, Inc. | 2014-06-01 |
| Study of Current Practice Which Compare the Rate of Prostate Cancer by Using 2 Kind of Transrectal Biopsies: 3 by IRM-echography Image Fusion and 12 Systematized Guided Echographies. (NCT02050542) | Assistance Publique - Hôpitaux de Paris | 2014-06-01 |
| Metformin Prostate Cancer Adjuvant Trial (NCT02176161) | NYU Langone Health | 2014-06-01 |
| A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer (NCT02059213) | University of Michigan Rogel Cancer Center | 2014-06-01 |
| Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy (NCT02153918) | National Cancer Institute (NCI) | 2014-05-31 |
| Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) (NCT01994590) | M.D. Anderson Cancer Center | 2014-05-19 |
| Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers (NCT02141490) | National Cancer Institute (NCI) | 2014-05-15 |
| Pharmacokinetic Food-effect Study of Abiraterone Acetate (AA) in Castration Resistant Prostate Cancer (NCT02730975) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2014-05-12 |
| Sexual and Urological Rehabilitation to Men Operated for Prostate Cancer and Their Partners (NCT02103088) | Danish Cancer Society | 2014-05-01 |
| Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients (NCT02209584) | Myriad Genetic Laboratories, Inc. | 2014-05-01 |
| Motorised Probe Holder Assisting Prostate Biopsies (NCT02132975) | AdministrateurCIC | 2014-05-01 |
| Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy (NCT02064673) | yair lotan | 2014-05-01 |
| Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (NCT02139371) | Rigshospitalet, Denmark | 2014-05-01 |
| Phase 1 of EC1169 In Patients With Recurrent MCRPC (NCT02202447) | Endocyte | 2014-05-01 |
| Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer (NCT02702856) | Exosome Diagnostics, Inc. | 2014-05-01 |
| Effects of a New Diagnostic Test on the Care of Prostate Cancer Patients: The ProMark™ Clinical Utility Study (NCT04550416) | Qure Healthcare, LLC | 2014-05-01 |
| Prostate Cancer Screening in Men With Germline BRCA2 Mutations (NCT02154672) | Yale University | 2014-05-01 |
| SHIP (Selinexor in Hormone Insensitive Prostate Cancer) (NCT02146833) | Karyopharm Therapeutics Inc | 2014-05-01 |
| Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) (NCT02077634) | Universität des Saarlandes | 2014-05-01 |
| Prospective Clinical Utility Study to Assess the Impact of Decipher on Treatment Decisions After Surgery (NCT02080689) | GenomeDx Biosciences Corp | 2014-05-01 |
| Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer (NCT02265159) | University of Zurich | 2014-05-01 |
| Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer (NCT02064582) | University of Texas Southwestern Medical Center | 2014-05-01 |
| The Effect of Propofol Based Total Intravenous Anesthesia on Oxidative Stress and Nitric Oxide (NCT02149628) | Yonsei University | 2014-05-01 |
| Feasibility Trial Of Image Guided External Beam Radiotherapy With Or Without High Dose Rate Brachytherapy Boost In Men With Intermediate-Risk Prostate Cancer (NCT01982786) | Canadian Cancer Trials Group | 2014-04-22 |
| Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate Cancer (NCT01804465) | University of California, San Francisco | 2014-04-22 |
| PET Imaging in MCI Following ADT for PCa (NCT02061345) | Imperial College London | 2014-04-01 |
| A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer (NCT02111187) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost. (NCT05786742) | CHU de Quebec-Universite Laval | 2014-04-01 |
| Evaluation Of Transperineal Ultrasound For Image Guidance In The Treatment Of Prostate Cancer in Men Following Prostatectomy (NCT02110667) | University of Vermont Medical Center | 2014-04-01 |
| ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate (NCT02106507) | Memorial Sloan Kettering Cancer Center | 2014-04-01 |
| Ga-68-NODAGA-MJ9 Compared to F-18-FCH PET/CT for Prostate Cancer Patients (NCT02111954) | University of Lausanne Hospitals | 2014-04-01 |
| Feasibility Study of an Intervention Therapeutic Education for Patients Treated With Androgen Deprivation (NCT02460549) | Institut de Cancérologie de la Loire | 2014-04-01 |
| Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Previously Treated With Enzalutamide, Androgen Receptor Positive Triple-Negative Breast Cancer Patients, and Men With ER Positive Breast Cancer (NCT02130700) | Innocrin Pharmaceutical | 2014-04-01 |
| Cultured Circulating Tumor Cells in Prostate and Other Cancers (NCT02123862) | Oscar Goodman, Jr. | 2014-04-01 |
| A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy (NCT02115828) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-04-01 |
| New Treatment Modalities for Localized Prostate Cancer (NCT05523856) | Fundacion IMIM | 2014-04-01 |
| Salvage Therapeutic Radiation With Enzalutamide and ADT in Men With Recurrent Prostate Cancer (STREAM) (NCT02057939) | Duke University | 2014-04-01 |
| MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism (NCT02102646) | Herlev Hospital | 2014-04-01 |
| Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer (NCT02757365) | West China Hospital | 2014-04-01 |
| Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer (NCT02198859) | University of Kansas Medical Center | 2014-04-01 |
| Living Well on Androgen Deprivation Therapy (NCT02108613) | British Columbia Cancer Agency | 2014-04-01 |
| Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer (NCT02077335) | CSSS de Gatineau | 2014-04-01 |
| A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer (NCT02083185) | Millennium Pharmaceuticals, Inc. | 2014-03-26 |
| Posterior Urethrovesical Anastomotic Reconstruction in Comparison to Conventional Urethrovesical Anastomosis (NCT05605171) | St. Joseph's Healthcare Hamilton | 2014-03-19 |
| Prospective Analysis of Robot-Assisted Surgery (NCT02292914) | Instituto do Cancer do Estado de São Paulo | 2014-03-10 |
| Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer (NCT02036918) | Duke University | 2014-03-01 |
| Open Label Phase Two Trial of Radium Ra 223 Dichloride With Concurrent Administration of Abiraterone Acetate Plus Prednisone in Symptomatic Castration-Resistant (Hormone-Refractory) Prostate Cancer Subjects With Bone Metastasis (NCT02097303) | Carolina Research Professionals, LLC | 2014-03-01 |
| Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation (NCT01607879) | Medical College of Wisconsin | 2014-03-01 |
| A Phase 1 Study to Evaluate the Effects of Fluconazole and Atorvastatin on the Pharmacokinetics of TAK-385 in Healthy Subjects (NCT02093390) | Millennium Pharmaceuticals, Inc. | 2014-03-01 |
| Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET) (NCT02080650) | Duke University | 2014-03-01 |
| Evaluation of Molecular Forms of PSA and Human Kallikrein 2 in a Cohort of Patients With Locally Resected Prostate Cancer But Biochemical Recurrence (NCT02070575) | Memorial Sloan Kettering Cancer Center | 2014-02-20 |
| Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure. (NCT06168890) | IRCCS San Raffaele | 2014-02-04 |
| Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC (NCT01995058) | Exelixis | 2014-02-01 |
| Cooking Class Intervention Project for Men With Prostate Cancer and Their Partners (NCT02954289) | University of British Columbia | 2014-02-01 |
| Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex (NCT01968447) | Leiden University Medical Center | 2014-02-01 |
| Single Fraction Early Prostate Irradiation (SiFEPI) (NCT02104362) | Centre Antoine Lacassagne | 2014-02-01 |
| Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer (NCT02049190) | Arno Therapeutics | 2014-02-01 |
| Longitudinal Evaluation of Intestinal, Haematological and Urinary Toxicity From Pelvic Irradiation for Prostate Cancer (NCT02803086) | IRCCS San Raffaele | 2014-02-01 |
| Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy (NCT01915316) | ProSight | 2014-02-01 |
| Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer (NCT01992042) | University Health Network, Toronto | 2014-02-01 |
| Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility Study (NCT01551576) | Stanford University | 2014-02-01 |
| Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy (NCT02121639) | University Hospital Southampton NHS Foundation Trust | 2014-01-29 |
| Abiraterone, Radiotherapy and Short-Term Androgen Deprivation in Unfavorable Localized Prostate Cancer (NCT01717053) | Duke University | 2014-01-17 |
| Abiraterone Acetate for Castrate Resistant Prostate Cancer (NCT01961843) | Massachusetts General Hospital | 2014-01-14 |
| Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer (NCT01630590) | M.D. Anderson Cancer Center | 2014-01-08 |
| An Extension Long-term Safety and Tolerability Trial of Degarelix in Chinese Patients With Prostate Cancer (NCT02015871) | Ferring Pharmaceuticals | 2014-01-01 |
| PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer (NCT02042053) | NYU Langone Health | 2014-01-01 |
| CAPSAICIN Trial: Assessing Capsaicin as a Chemopreventive Agent for Prostate Cancer (NCT02037464) | Sunnybrook Health Sciences Centre | 2014-01-01 |
| The Effect of Different Doses of Remifentanil on Kidney Function During Robot Assisted Prostatectomy - A Retrospective Study (NCT02041559) | Yonsei University | 2014-01-01 |
| Hypofractionated Image Guided Proton Therapy for Low andIntermediate Risk Prostate Cancer (NCT02040610) | Provision Center for Proton Therapy | 2014-01-01 |
| Improving Compliance With Medical Testing Guidelines (NCT02430948) | Beth Israel Medical Center | 2014-01-01 |
| A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer (NCT02042885) | Otsuka Novel Products GmbH | 2014-01-01 |
| TAK-700 in Castration Resistant Prostate Cancer (NCT01658527) | European Organisation for Research and Treatment of Cancer - EORTC | 2014-01-01 |
| Prostate Screening Study Using MRI in BRCA Carriers (NCT01990521) | Toronto Sunnybrook Regional Cancer Centre | 2014-01-01 |
| The Effects of Pilates in Muscle Strength of the Pelvic Floor as Treatment of Post Prostatectomy Urinary Incontinence (NCT02645136) | Universidade Estadual de Londrina | 2014-01-01 |